Top Markets
Coin of the day
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
Clasificación en acciones #14050
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
Precio por acción
$0.88012714
Última sincronización: 2026-08-31
Capitalización bursátil
$439.58M
Cambio (1 día)
-4.01%
Cambio (1 año)
1,131.97%
País
FR
Comercio Valerio Therapeutics S.A. (ALVIO)

Categoría

Historial de desdoblamientos de acciones de Valerio Therapeutics S.A. (ALVIO)
La acción Valerio Therapeutics S.A. (símbolo: ALVIO) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Sep 01, 2026.
Una acción ALVIO comprada antes de Sep 01, 2026 equivaldría hoy a 0 acciones ALVIO.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH